skip to primary navigationskip to content
 

Study Updates

October 3, 2018

The CCNR and Delta Trial Team would like to extend a heartfelt thank you for the generous support from everyone who has enrolled in the Delta Trial. We have now closed recruiting after receiving an enthusiastic response from the 5,400+ people who enrolled and 2,500+ who have so far received their results reports.

With follow-up beginning shortly, we are now analysing the anonymised data produced and will be publishing the results after the trial finishes. Please feel free to contact us with any questions you may have and keep an eye on the CCNR Facebook , Twitter and this lab page for updates related to this work. Hearing from those of you who are interested and have taken part in this research inspires us to keep working towards the goal of early and accurate diagnosis for people living with mental health challenges.

September 3, 2018

Thank you to the nearly 4,500 participants who have signed up and over 2,000 who have completed the Delta Trial. Your help is bringing us closer to the ultimate goal of early and accurate mental health diagnosis. We are still looking for participants who are female and have been diagnosed with depression within the past 5 years or are suffering from low mood, but have not yet received a diagnosis to sign up at www.deltatrial.co.uk. Please share our video explaining the trial with anyone you know that fits these criteria. With your help, we hope to achieve early and accurate diagnosis for people with mental health challenges.

 

August 3, 2018

Thank you to the nearly 4,000 participants who have signed up and over 1,500 who have completed the Delta Trial. Your help is bringing us closer to the ultimate goal of early and accurate mental health diagnosis. We are still looking for participants who have been diagnosed with depression within the past 5 years or are suffering from low mood, but have not yet received a diagnosis to sign up at www.deltatrial.co.uk. Please share this short video with anyone you know that fits these criteria. With your help, we hope to achieve early and accurate diagnosis for people with mental health challenges.

 

June 29, 2018

Thank you to the 1,909 participants who have signed up and 581 who have completed the Delta Trial. Your help is bringing us closer to the ultimate goal of early and accurate mental health diagnosis. We are still looking for participants who are living in the UK, between the ages of 18 and 45, and have either been diagnosed with depression within the past 5 years or are suffering from low mood, but have not yet received a diagnosis to sign up at www.deltatrial.co.uk. Please share this link or video with anyone you know that fits these criteria. With your help, we hope to achieve early and accurate diagnosis for people with mental health challenges.

 

June 3, 2018

Thank you to the 631 participants who have signed up and 157 who have completed the Delta Trial. Your help is bringing us closer to the ultimate goal of early and accurate mental health diagnosis. We are still looking for participants who are living in the UK, between the ages of 18 and 45, and have either been diagnosed with depression within the past 5 years, been diagnosed with bipolar disorder, or are suffering from low mood, but have not yet received a diagnosis to sign up at www.deltatrial.co.uk. Please share this link or video with anyone you know that fits these criteria. With your help, we hope to achieve early and accurate diagnosis for people with mental health challenges.

 

April 27, 2018

We have launched recruitment for the Delta Trial !!

Image result for launch pictures

 

 

 

 

 

March 12, 2018

Following the very encouraging results from the Spot Depression Beta Study, we have now developed a more extensive questionnaire and have also optimised our biomarker methods substantially. We will be in touch with previous participants from the Beta Study (those of you who gave permission to re-contact you), to inform you about our Spot Depression Delta Trial.

Hopefully we will be able to begin to recruit for the Delta Trial by mid-April. The main difference between the Beta Study and Delta Trial are that we will be able to provide you with feedback of your results from the questionnaire and for those of you who also participate in the blood spot collection and clinical interview, we will also be able to send you feedback about the interview.

 

May 25, 2017

It’s been a while since you’ve heard from us here at the Cambridge Centre for Neuropsychiatric Research (CCNR). We’ve been doing a lot of work to analyse the 550 dried blood spot samples you sent us! We’d like to emphasize again how grateful we are for your generous support of our study.

We measured the concentrations of 94 different proteins in your dried blood spots using mass spectrometry technology. We then conducted a statistical analysis of these proteins and your questionnaire responses, from which we have some interesting and very promising results. We hope these results will contribute to development of a diagnostic test for bipolar disorder and major depressive disorder. This has the potential to lead to earlier diagnosis and treatment of these disorders, improve our understanding of them, and produce better outcomes for patients.

We will be publishing a full account of these results in a scientific journal (these things take time, so please have patience with us!). As always, we will keep updating our website and Facebook/Twitter pages to keep you informed.

In the meantime, we will be launching a follow-up study to the Spot Depression study this year. This will consist of a carefully designed digital questionnaire to be completed over the course of several days (with plenty of interesting and helpful material included)! The digital questionnaire can be answered online on a desktop computer or mobile device and will consist of questions about your personality, lifestyle, psychiatric symptoms and history, and other factors important to mental wellbeing. We will be seeking individuals experiencing depressive symptoms for this study, and particularly those with a prior diagnosis of bipolar disorder or major depressive disorder. If you meet the criteria and are willing to help, your experience in the Spot Depression study would make you an incredibly valuable participant for us. We will publish an update with more information when we begin recruitment for this study. 

Thanks again for your valuable contributions!

 

September 14, 2016

We have received over 550 dried blood spot cards from participants in the Spot Depression study! We are now in the process of preparing samples for analysis by mass spectrometry. 

 

August 04, 2016

Thank you to everyone who has helped with our study! We have now closed recruitment. We will keep you all updated via our website and our Facebook and Twitter pages.

 

June 25, 2016

Thanks to everyone who has participated in our Spot Depression study! We have had an overwhelming number of sign-ups and are immensely grateful for your support of our research. We are now carefully going through your responses and will contact you via email to let you know whether or not you will receive a kit. If you have not yet received an email, we appreciate your patience.

We are still looking for controls who have not been diagnosed with any psychiatric disorder - please do fill out our online questionnaire at www.spot-depression.org if you meet this criteria. We are hoping to close the study soon and will keep you all updated.

 

Thank you to the 631 participants who have signed up and 157 who have completed the Delta Trial. Your help is bringing us closer to the ultimate goal of early and accurate mental health diagnosis. We are still looking for participants who are living in the UK, between the ages of 18 and 45, and have either been diagnosed with depression within the past 5 years, been diagnosed with bipolar disorder, or are suffering from low mood, but have not yet received a diagnosis to sign up at www.deltatrial.co.uk. Please share this link or video with anyone you know that fits these criteria. With your help, we hope to achieve early and accurate diagnosis for people with mental health challenges.